Drug profile · INN
raltegravir potassium
RALTEGRAVIR VIATRIS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
raltegravir potassium (RALTEGRAVIR VIATRIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN raltegravir potassium
Brand RALTEGRAVIR VIATRIS
Route ORAL
Formulation POWDER
ATC code J05AJ01
Frequently asked questions
What is raltegravir potassium?
raltegravir potassium (RALTEGRAVIR VIATRIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for raltegravir potassium?
RALTEGRAVIR VIATRIS is a marketed brand name for raltegravir potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of raltegravir potassium?
raltegravir potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.